Clinical Trial Update: Risedronate in Postmenopausal Women With Low Bone Density [Phase 2]

View source ↗

Summary

Phase 2 trial of risedronate in postmenopausal women with low bone density has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Sanofi | Conditions: OSTEOPOROSIS, POSTMENOPAUSAL | Phase 2 | Status: COMPLETED